RT @vasculitides: Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy an…
24 followers
413 followers
RT @vasculitides: Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy an…
148 followers
RT @vasculitides: Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy an…
4,092 followers
Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE) - RCT - Arthritis Res Ther https://t.co/Yg6s6YXYXc